Introduction
Diabetes is preceded by a state known as Impaired Glucose Regulation (IGR), or pre-diabetes. While well-studied in older populations, the rise of "early-onset" metabolic disorders in young adults (under 45) presents a significant public health challenge. This study investigates the role of irisin, a muscle-derived hormone (myokine) released during exercise, as a potential biomarker for IGR in young Chinese men. Irisin is known to promote the "browning" of white adipose tissue, enhancing energy expenditure and systemic metabolism.
Methods
This cross-sectional study involved 86 Chinese men aged 18–45 years. Participants were categorized into two groups based on an Oral Glucose Tolerance Test (OGTT):
- Normal Glucose Tolerance (NGT): 45 subjects.
- Impaired Glucose Regulation (IGR): 41 subjects.
Researchers measured anthropometric data (BMI, waist circumference) and biochemical markers, including fasting plasma glucose (FPG), 2-hour post-load glucose (2hPG), lipids, and serum irisin levels. Insulin resistance was quantified using the HOMA-IR index.
Results
The study found significant metabolic differences between the two groups. Subjects in the IGR group exhibited higher BMI, waist circumference, and insulin resistance (HOMA-IR) compared to the NGT group. Crucially, serum irisin levels were significantly lower in the IGR group (4.43 ± 1.44 µg/mL) than in the NGT group (6.25 ± 1.46 µg/mL).
Further analysis revealed that the prevalence of "low irisin" was substantially higher in the IGR group (75.6%) compared to the healthy group (26.7%). To determine if irisin was an independent predictor of IGR, the team performed multiple logistic regression.
The regression analysis identified both irisin (OR=0.110, P=0.000) and HOMA-IR (OR=5.586, P=0.011) as independent risk factors. An Odds Ratio of 0.110 for irisin indicates that higher levels of this hormone are strongly protective against the development of IGR.
Discussion and Conclusion
The findings suggest that reduced irisin levels are closely associated with impaired glucose homeostasis in young men. While some studies in older or more obese populations have suggested "irisin resistance" (where levels rise to compensate for metabolic failure), this study indicates that in the early stages of glucose impairment among young adults, low irisin is a clear warning sign.
The study is limited by its small sample size and cross-sectional design, which prevents establishing a definitive causal link. However, the results highlight irisin as a promising independent biomarker for early metabolic intervention. Future longitudinal research is needed to confirm if irisin can predict the progression from pre-diabetes to Type 2 Diabetes.
Summary updated